Literature DB >> 29039490

IL‑8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF‑κB pathway in prostate cancer.

Yidi Guo1, Ying Zang1, Lianzheng Lv1, Feng Cai1, Tingting Qian1, Guoying Zhang1, Quancheng Feng2.   

Abstract

Interleukin-8 (IL-8) possesses tumorigenic and proangiogenic properties, and is overexpressed in many human cancer types. However, only few studies have demonstrated the mechanisms of action of IL‑8 regarding the ability to promote proliferation and to inhibit apoptosis in prostate cancer. Here, the aim of the present study was to investigate the effects of IL‑8 on the prostate cancer cell line and determine possible mechanisms underlying its effect. In this study, IL‑8 was shown to be significantly upregulated in prostate cancer compared with paired normal control tissues. The data showed that IL‑8 exhibits direct oncogenicity, which significantly induced cell proliferation, invasion and attenuated apoptosis in prostate cancer cells via signal transducer and activator of transcription 3/protein kinase B/nuclear factor‑κB signaling pathways. In conclusion, modulation of IL‑8 expression or its associated signaling pathway may provide a novel working mechanism of IL‑8 in prostate cancer, and a promising strategy for controlling the progression and metastasis of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29039490     DOI: 10.3892/mmr.2017.7747

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  25 in total

1.  A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance.

Authors:  Jacqueline Olender; Bi-Dar Wang; Travers Ching; Lana X Garmire; Kaitlin Garofano; Youngmi Ji; Tessa Knox; Patricia Latham; Kenneth Nguyen; Johng Rhim; Norman H Lee
Journal:  Mol Cancer Res       Date:  2019-07-02       Impact factor: 5.852

2.  Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8/STAT3, KIT/STAT3, and IL-2/CD25/Treg axes.

Authors:  Lia Furlaneto Marega; Janine Schincariol Sabino; Marcus Vinicius Pedroni; Marcelo Teocchi; Carolina Lanaro; Dulcinéia Martins de Albuquerque; Irene Pereira Dos Santos; Fernando Ferreira Costa; Maria Marluce Dos Santos Vilela
Journal:  Immunol Res       Date:  2021-08-14       Impact factor: 2.829

3.  MAEL Augments Cancer Stemness Properties and Resistance to Sorafenib in Hepatocellular Carcinoma through the PTGS2/AKT/STAT3 Axis.

Authors:  Chaoran Shi; Dora Lai-Wan Kwong; Xue Li; Xia Wang; Xiaona Fang; Liangzhan Sun; Ying Tang; Xin-Yuan Guan; Shan-Shan Li
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

4.  Molecular mechanism of gossypol mediating CCL2 and IL‑8 attenuation in triple‑negative breast cancer cells.

Authors:  Samia S Messeha; Najla O Zarmouh; Patricia Mendonca; Carolyn Cotton; Karam F A Soliman
Journal:  Mol Med Rep       Date:  2020-06-15       Impact factor: 2.952

Review 5.  Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis.

Authors:  Timothy O Adekoya; Ricardo M Richardson
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

6.  A novel CXCL8 analog is effective in inhibiting the growth via cell cycle arrest and attenuating invasion of Lewis lung carcinoma.

Authors:  Su-Ya Hsu; Hui-Yuan Yu; Wei-Chen Lee; Chia-En Hsiao; Chih-Lung Wu; Hsi-Tsung Cheng; Li-Jin Lin; Fang Li; Yu-Ting Chou; Jya-Wei Cheng
Journal:  Onco Targets Ther       Date:  2019-09-16       Impact factor: 4.147

Review 7.  Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance.

Authors:  Maddison Archer; Navneet Dogra; Natasha Kyprianou
Journal:  Cancers (Basel)       Date:  2020-10-15       Impact factor: 6.639

8.  Interleukin-6 and Interleukin-8 Regulate STAT3 Activation Migration/Invasion and EMT in Chrysophanol-Treated Oral Cancer Cell Lines.

Authors:  Po-Chih Hsu; Yi-Hsuan Chen; Ching-Feng Cheng; Chan-Yen Kuo; Huey-Kang Sytwu
Journal:  Life (Basel)       Date:  2021-05-05

9.  Relevance of Interleukins 6 and 8 Single Nucleotide Polymorphisms in Prostate Cancer: A Multicenter Study.

Authors:  Amany A Ghazy; Mohammed Jayed Alenzi
Journal:  Prostate Cancer       Date:  2021-07-06

10.  (-)-Catechin-7-O-β-d-Apiofuranoside Inhibits Hepatic Stellate Cell Activation by Suppressing the STAT3 Signaling Pathway.

Authors:  Yong Joo Park; Dong Min Kim; Mi Ho Jeong; Jae Sik Yu; Hae Min So; In Jae Bang; Ha Ryong Kim; Seung-Hwan Kwon; Ki Hyun Kim; Kyu Hyuck Chung
Journal:  Cells       Date:  2019-12-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.